Breaking Indiana Fever Coach Addresses WNBA Divisiveness and “Hate Mongering” Trump Used Elaborate Security Ruse for Turkey Travel Amid Iran Threat Federal Judge Blocks Trump Administration’s Federal Voter List Executive Order Patriot Games Challenge Features 120 Student Athletes Competing for Scholarships FDA Proposes Changes to Food Ingredient Safety Notification Process

Tuesday August 11, 2026

Reporter

Alpha Tau Medical Ltd.

4Articles Published

4Communities Covered

Published Articles

Press Release

Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 10

Press Release

Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

Aug 10

Press Release

Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study’s Pre-Specified Threshold for Success

Jul 21

Press Release

Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center

Jul 15